BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2007
View Archived Issues
Immune responses, clinical benefit seen with T-cell vaccination in rheumatoid arthritis
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patent literature
Read More
Recent patents describe novel agents for anxiety, depression, psychosis etc.
Read More
Novel treatment options for thrombotic disorders reported in recent patents
Read More
Phase II results suggest tetomilast is active in ulcerative colitis
Read More
Statins linked to lower risk of infection-related mortality
Read More
5-HT4 activation inhibits Abeta secretion and increases survival of neurons oversecreting Abeta
Read More
Pharmacopeia and Organon establish new alliance
Read More
VASTox signs chemical genomics agreements
Read More
RotaTeq prescribing information updated
Read More
Effect of rifalazil investigated on atherosclerotic changes in the carotid artery
Read More
Smallpox drug SIGA-246 studied in phase I trial
Read More
Agreement to study FavId with Leukine in B-cell NHL
Read More
Sanofi pasteur licenses ChimeriVax-JE vaccine from Acambis
Read More
FDA extends review of rimonabant
Read More
Phase I study under way for DARA compound PS-433540
Read More
AndroScience files IND for ASC-J9 for acne
Read More
Tikvah Therapeutics licenses compounds for anxiety-related disorders
Read More
BrainStorm's adult stem cell technology studied in Parkinson's disease in primates
Read More
Treatment under way in phase II study of Litx therapy in glioma
Read More
Completion of phase III studies for Metvix with Aktilite
Read More
IPI-504 studied for NSCLC
Read More
Teverelix LA has same effect on testosterone suppression in normal and obese subjects
Read More
Bavituximab shows signs of dose dependent antiviral activity in chronic HCV
Read More
FDA accepts for review two sNDAs for Januvia
Read More
Roche files for Tamiflu 30 and 45 mg capsules in Europe
Read More
Satraplatin NDA filing completed
Read More